
Carbometrics
Specialist chemistry company with core competency of the design, synthesis and derivatisation of highly selective and robust carbohydrate-binding molecules.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 | round | |
* | £2.1m | Seed | |
Total Funding | 000k |
Related Content
Carbometrics is a pioneering company in the healthcare sector, focusing on the development of advanced glucose sensor technology. The company specializes in Biomimetic Glucose Binding Molecules (GBMs), which are designed to offer high selectivity towards glucose, even in complex biological mixtures. These GBMs are robust and have a multi-year operational potential, making them ideal for long-term use in Continuous Glucose Monitors (CGMs). Carbometrics operates in the medical device market, primarily serving clients in the diabetes care industry. The business model revolves around partnering with other companies to integrate their proprietary GBM technology into next-generation glucose sensors. Revenue is generated through these partnerships and licensing agreements. The company's mission is to improve the quality of life for people with diabetes by enabling more accurate and reliable glucose monitoring solutions.
Keywords: Biomimetic, Glucose, Binding Molecules, Diabetes, Continuous Glucose Monitors, Selectivity, Stability, Healthcare, Medical Devices, Partnerships.